
Cadigran 1mg Injection
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Granisetron (1mg)
Overview Cadigran 1mg Injection
Granicain 1mg Injection, an antiemetic, effectively manages nausea and vomiting resulting from surgery, chemotherapy, or radiation. However, it doesn't alleviate other cancer treatment side effects. Administered by a healthcare provider, this injection should be used precisely as directed. Continued use is crucial until medically discontinued, potentially transitioning to oral medication thereafter. Common side effects, such as injection site discomfort, headache, bowel irregularities (constipation or diarrhea), and fatigue, usually resolve upon cessation. Persistent or bothersome symptoms warrant medical consultation for management strategies. Prior to treatment, disclose any heart, liver, or gastrointestinal obstruction issues, and list all concurrent medications, particularly those for epilepsy, cardiac conditions, cancer, or depression, as interactions may occur. Pregnant or breastfeeding individuals should consult their healthcare team before use.
Primary Ingredients of Cadigran 1mg Injection
The provided text is "undefined," which has no meaning to rephrase. Therefore, no rewritten text can be provided.
Uses of Cadigran 1mg Injection
Chemotherapy-induced emesis
Major Benefits of Cadigran 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cadigran 1mg Injection:
- Injection site pain
- Constipation
- Diarrhea
- Headache
- Weakness
- Insomnia (difficulty in sleeping)
How to use Cadigran 1mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Cadigran 1mg Injection works:
Cadigran 1mg Injection is used to prevent nausea and vomiting. This antiemetic medication functions by inhibiting serotonin, a neurotransmitter in the brain that triggers these side effects, often experienced during chemotherapy or post-surgery.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption while using Cadigran 1mg Injection is undetermined. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Cadigran (1mg) is typically deemed safe for use in pregnant individuals. Preclinical trials in animals revealed minimal or absent harmful effects on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Cadigran 1mg Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible harm to the infant.
DrivingSAFE
Administering Cadigran 1mg Injection typically does not impair driving capabilities.
KidneySAFE IF PRESCRIBED
The use of Cadigran 1mg Injection in individuals with kidney impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Cadigran 1mg Injection in individuals with hepatic impairment is likely safe. Current evidence indicates dose modification may not be necessary, but physician consultation is recommended.
What if you forget to take Cadigran 1mg Injection :
Should you forget a Cadigran 1mg Injection dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cadigran 1mg Injection
| Label | Value |
|---|---|
| Chemical Category | Indazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | 5-HT3 receptor blockers |
